Events / Programs

By participating in sponsored events (in-person or webcast), you will have the opportunity to be kept informed and educated on therapies, current news, drug trials, and other MS topics. Events are held across the country so you can stay connected with up to date information and the multiple sclerosis community in your area.(Note: Most events can be attended even if not on their therapy)
 Program Locator
 
Ampyra - approved in 2013.
(Extended Release Pill)
"the only prescription medicine indicated to help improve walking in adults with MS. This was demonstrated by an increase in walking speed"

http://ampyra.com/events/
Aubagio -by: Sanofi Genzyme, approved in 2012.
(A once a day oral pill)
"Is approved by FDA to treat relapsing forms of MS."
www.aubagio.com/events
Avonex -by: Avonex,approved in 1996.
(A
once a week injection-intramuscular)

"Is approved by FDA to treat relapsing forms of MS."
www.avonex.com/en_us/home/additional-support/ms-events.html
Copaxone (Shared solutions) by: Teva, approved in 1996.
(*40mg three day per week injection-
subcutaneously. *20mg A daily injection-subcutaneously)
"Is indicated for the reduction of the frequency of relapses in relapsing-remitting MS, including patients who have experienced a first clinical episode and have MRI features consistent with MS."
www.copaxone.com/MultipleSclerosisCommunity/RrmsEventLocator
Gilenya by: Norvartis, approved in 2010.
(A once a day oral pill)
"Is a prescription medication use to treat relapsing forms of MS."
www.gilenya.com/c/living-with-ms/events
Lemtrada by: Genzyme, approved in 2014.
(First Treatment: 12 mg/day on 5 consecutive days (60 mg total dose). Second Treatment: 12 mg/day on 3 consecutive days (36 mg total dose) administered 12months after the first treatment course.)
"is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS). Because of its risks, LEMTRADA is generally used in people who have tried 2 or more MS medicines that have not worked well enough."
www.lemtrada.com/events
Mallinckrodt (formerly Questcor)
(injection-subcutaneously or inner muscular)
"Acthar is a self-injection. This gives you the flexibility to inject it at home and on your own schedule—wherever and whenever is best"
www.msrelapseprograms.com/

MS ActiveSource

Multiple drug company programs

www.msactivesource.com/ms-events.xml


Ocrevus by: Genentech, approved in 2017.
(The first dose is given as 2 separate infusions, 2 weeks apart. Every dose after your first will be given as 1 single infusion 6 months apart)
"Is approved by the FDA to treat relapsing  and primary progressive forms of MS."
www.ocrevusevents.com/10312017/#/
Plegridy by: Biogen Idec, approved in 2014.
(A bi-weekly injection-subcutaneously)
"Is approved by FDA to treat the long-term treatment of relapsing forms of MS."
www.plegridy.com/support/events
Rebif - (MS Life Lines) by: EMD Serono, approved in 2002.
(A three day per week injection-
subcutaneously)
"Is a prescription medication use to treat relapsing forms of MS."

www.mslifelines.com/ms-lifelines-live-events

 
Tecfidera by: Biogen Idec, approved in 2013.
(A daily oral pill)
"approved by the FDA for the treatment of people with relapsing forms of MS"        

www.tecfidera.com/en_us/home/additional-support/events.html
TYSABRI by: Biogen Idec, approved in 2006.
(A infusion (IV) therapy given once every four weeks)

"Is a prescription medication approved for adult patients with relapsing forms of MS."
www.tysabri.com/en_us/home/support/events.html
Event Locator
 
MSAA Calendar of Events
http://support.mymsaa.org/site/PageServer?pagename=Calendar_of_Events
Nancy Davis Foundation
Race to Erase MS Gala & symposium
www.erasems.org/events/

www.erasems.org/
NMSS
Locate: Events, Fundraising, Symposiums & Galas
Events & Fundraising:
www.nationalmssociety.org/Search?q=events&stype=0&chap=0


Symposiums:
www.nationalmssociety.org/Search?q=symposium&stype=0&chap=0

Galas:
www.nationalmssociety.org/Search?q=gala&stype=0&chap=0